Source: Eur Respir J, 49 (6) 1700007; 10.1183/13993003.00007-2017
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mariëlle C. van de Veerdonk, Anna E. Huis in t Veld, J. Tim Marcus, Nico Westerhof, Martijn W. Heymans, Harm-Jan Bogaard, Anton Vonk-Noordegraaf. Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension. Eur Respir J, 49 (6) 1700007; 10.1183/13993003.00007-2017

Member's Comments

No comment yet.

Related content which might interest you: How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017 Year: 2017 Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012 Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Effects of acute increases in right ventricular preload and afterload on pulmonary artery pulse pressure in a chronic thromboembolic hypertension model Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 The right ventricle in pulmonary arterial hypertension Source: Eur Respir Rev 2014; 23: 476-487 Year: 2014 Differences of right ventricular diastolic stiffness in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Diagnosis of left ventricular diastolic dysfunction using echocardiography in COPD patients with pulmonary arterial hypertension Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 31: 1160-1166 Year: 2008 Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases Year: 2008 Prolonged overcirculation-induced pulmonary arterial hypertension, as a cause of right ventricular failure Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension Year: 2011 Changes in right ventricular mass are unrelated to changes in pulmonary pressures in pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Left ventricular diastolic function in patients with high altitude-induced pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 98s Year: 2002 Macitentan in pulmonary hypertension due to left ventricular dysfunction Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 Year: 2018